Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Esnault

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|June 27, 2020
QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract InfectionSok-Sithikun Bun, Philippe Taghji, Johan Courjon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 23, 2021
Cohort study: "Outcomes of kidney transplantation in patients with prosthetic heart valves"Hajar Ouahmi, Pamela Moceri, Kevin Zorzi, et al.
Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.
Cancers|February 24, 2019
The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back AgainPaul Hofman, Nicholas Ayache, Pascal Barbry, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GNMarie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.
Journal of Nephrology|July 5, 2021
Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndromeMarie-Sophie Meuleman, Sophie Guilmin-Crépon, Aurélie Hummel, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
Nature Genetics|March 13, 2012
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephronHélène Louis-Dit-Picard, Julien Barc, Daniel Trujillano, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Pharmacology and Therapeutics|June 27, 2020
QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract InfectionSok-Sithikun Bun, Philippe Taghji, Johan Courjon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 23, 2021
Cohort study: "Outcomes of kidney transplantation in patients with prosthetic heart valves"Hajar Ouahmi, Pamela Moceri, Kevin Zorzi, et al.
Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.
Cancers|February 24, 2019
The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back AgainPaul Hofman, Nicholas Ayache, Pascal Barbry, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GNMarie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.
Journal of Nephrology|July 5, 2021
Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndromeMarie-Sophie Meuleman, Sophie Guilmin-Crépon, Aurélie Hummel, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
Nature Genetics|March 13, 2012
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephronHélène Louis-Dit-Picard, Julien Barc, Daniel Trujillano, et al.
Pageof 4